Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

A Humanized Diabody-Ribonuclease Fusion Protein Mediates Potent and Selective Killing of CD22-Positive Tumor Cells

Arndt, Michaela1; Vu, Bang K.2; Martin, Andrew C.3; Liu, Huaitian2; Newton, Dianne L.2; Seeber, Siegfried1; Rybak, Susanna M.4; Krauss, Jürgen1

doi: 10.1097/01.cji.0000211343.73588.59
ABSTRACTS: NEW AGENTS IN TARGETED THERAPIES

1Medical Oncology & Cancer Research, University of Duisburg-Essen, Essen, Germany

2Nation Cancer Institute at Frederick, SAIC, Frederick, MD

3Biochemistry and Molecular Biology, University College London, London, United Kingdom

4Bionanomics, Green Cove Springs, FL

Abstracts for the 21st Annual Scientific Meeting of the International Society for Biological Therapy of Cancer

(Primary Authors are Italicized)

© 2006 Lippincott Williams & Wilkins, Inc.